US Patent Issued to Nxera Pharma UK on May 6 for "Oxime compounds as agonists of the muscarinic M 1 and/or M 4 receptor" (British Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,512, issued on May 6, was assigned to Nxera Pharma UK Ltd. (Cambridge, Great Britain).

"Oxime compounds as agonists of the muscarinic M 1 and/or M 4 receptor" was invented by Giles Albert Brown (Cambridge, Great Britain) and Benjamin Gerald Tehan (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to compounds that are agonists of the muscarinic M1 and/or M4 receptor and which are useful in the treatment of diseases mediated by the muscarinic M1 and M4 receptors. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds provided are of formu...